2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...
Meet Veristat at SCOPE: Powering the Future of Clinical Research February 2-5, 2026
🔬 Advancing Clinical Research with Strategic Partnership
Veristat is proud to be attending SCOPE 2026, where industry leaders gather to shape the future of clinical trials, data strategy, and operational excellence. As the clinical development landscape evolves and expectations rise, our team is ready to forge new collaborations and share insights that accelerate progress and improve outcomes.
👥 Meet the Veristat Team at SCOPE
Connect with our experts to explore how Veristat’s tailored solutions can advance your clinical and regulatory milestones:
-
Kim Boerike, Chief Operating Officer
-
AJ Mills, Vice President, Global Commercial
-
Caroline Hyde, Business Development Manager
-
Ryan Butcher, Team Lead, Account Development
📅 Schedule a meeting in advance
By completing the form on this page. We welcome the opportunity to discuss your upcoming programs and how Veristat can be a strategic partner in your success.
💡 Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
Let’s shape the future of clinical research—together.
Schedule A Meeting
Meet with us at SCOPE: Powering the Future of Clinical Research February 2-5, 2026
5 min read
ASCO 2026: ADCs Are Redefining What Targeted Therapy Can Do
Jul 2, 2026 Veristat Blog
Antibody-drug conjugates — or ADCs — are not new. The concept of a "magic bullet" that delivers a cytotoxic payload...